NKA Bio
San Diego, United States· Est.
NKA Bio was founded with a mission to improve trauma care by solving shock. The company is focused on its primary product NKA01 for Trauma Resuscitation. The early-stage pipeline in development includes programs for septic shock, acute lung injury, and heart attack resuscitation.
Private Company
Total funding raised: $20M
About
NKA Bio was founded with a mission to improve trauma care by solving shock. The company is focused on its primary product NKA01 for Trauma Resuscitation. The early-stage pipeline in development includes programs for septic shock, acute lung injury, and heart attack resuscitation.
AntibodiesBiologics
Funding History
1Total raised:$20M
Seed$20M